Skin cancer drug shows promise in early trial

(AFP) UPDATED 2009-09-03

Scientists say an early clinical trial of an experimental medication called GDC-0449 has shown promising results. In the study of 33 people with metastatic basal cell skin cancers, 18 patients showed tumor shrinkage or an overall improvement in skin cancer symptoms. Scientists say the pill works by blocking a specific cell regulator called a Hedgehog signaling pathway. Read full story >

See all Skin Cancer News

This helped!

Note: All clinical content on this site is physician-reviewed, except material generated by our community members.

Featuring Content From:

We comply with the HONcode standard for
trustworthy health information: verify here.

By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.

Healthcentral.com is part of Remedy Health Media

Skin cancer drug shows promise in early trial

People who read this also read...

What the community is saying...

Doctor Green Answers Your Questions about Melanoma

Merely Me